University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Edward Gerstenfeld, M.D.

Chief of Cardiac Electrophysiology and Arrhythmia

Dr. Edward P. Gerstenfeld is chief of the Cardiac Electrophysiology and Arrhythmia Service at UCSF Medical Center. His expertise includes the treatment of arrhythmia, or irregular heartbeats, with catheter ablation, including endocardial and epicardial ablation, for atrial fibrillation, supraventricular tachycardias and ventricular tachycardia. He also specializes in treating patients with inherited arrhythmia syndromes such as arrhythmogenic right ventricular cardiomyopathy (ARVC), hypertrophic cardiomyopathy (HOCM), Brugada syndrome, long QT syndrome and adult congenital heart disease. Treatments include implantation of pacemakers, defribrillators and cardiac resynchronization therapy.

In his research, Gerstenfeld studies the mechanisms of arrhythmia, signal processing, electrocardiography, new technologies for mapping and ablation of arrhythmias. He is the primary investigator for several clinical trials. Gerstenfeld earned a medical degree at Northwestern Medical School in Chicago and a master's of science in biomedical engineering at Northwestern University in Chicago. He completed a residency at Beth Israel Hospital in Boston, a cardiology fellowship at the University of Massschusetts in Worcester, a research fellowship at UCSF and an electrophysiology fellowship at the University of Pennsylvania in Philadelphia. He is a fellow of the American College of Cardiology and a member of the Heart Rhythm Society and American Heart Association. He has published numerous manuscripts and book chapters and lectures on mapping and treating arrhythmias. He is an associate professor of medicine at UCSF.


Cardiac Electrophysiology and Arrhythmia Service
400 Parnassus Ave., Floor B1, Room 094
San Francisco, CA 94143
Phone: (415) 353-2554
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

More about Edward Gerstenfeld


Northwestern University School of Medicine 1993


Beth Israel Hospital 1996


University of Massachusetts Medical School, Worcester, Cardiology 1999
University of Massachusetts Medical School, Worcester, Research 2000
Hospital of the University of Pennsylvania, Electrophysiology 2001

Selected Research and Publications

  1. Kawamura M, Hsu JC, Vedantham V, Marcus GM, Hsia HH, Gerstenfeld EP, Scheinman MM, Badhwar N. Clinical and electrocardiographic characteristics of idiopathic ventricular arrhythmias with right bundle branch block and superior axis: Comparison of apical crux area and posterior septal left ventricle. Heart Rhythm. 2015 Jun; 12(6):1137-44.
  2. Hoffmayer KS, Gerstenfeld EP. Contact force-sensing catheters. Curr Opin Cardiol. 2015 Jan; 30(1):74-80.
  3. Calkins H, Gerstenfeld EP, Schilling R, Verma A, Willems S. RE-CIRCUIT Study-Randomized Evaluation of Dabigatran Etexilate Compared to Warfarin in Pulmonary Vein Ablation: Assessment of an Uninterrupted Periprocedural Anticoagulation Strategy. Am J Cardiol. 2015 Jan 1; 115(1):154-5.
  4. Campos B, Jauregui ME, Marchlinski FE, Dixit S, Gerstenfeld EP. Use of a novel fragmentation map to identify the substrate for ventricular tachycardia in postinfarction cardiomyopathy. Heart Rhythm. 2015 Jan; 12(1):95-103.
  5. Kawamura M, Gerstenfeld EP, Vedantham V, Rodrigues DM, Burkhardt JD, Kobayashi Y, Hsia HH, Marcus GM, Marchlinski FE, Scheinman MM, Badhwar N. Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum: epicardial idiopathic ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1152-8.
  6. Tanaka Y, Genet M, Chuan Lee L, Martin AJ, Sievers R, Gerstenfeld EP. Utility of high-resolution electroanatomic mapping of the left ventricle using a multispline basket catheter in a swine model of chronic myocardial infarction. Heart Rhythm. 2015 Jan; 12(1):144-54.
  7. Nazer B, Gerstenfeld EP. Catheter ablation of ventricular tachycardia in patients with post-infarction cardiomyopathy. Korean Circ J. 2014 Jul; 44(4):210-7.
  8. Singh DK, Viswanathan MN, Tanel RE, Lee RJ, Lee BK, Marcus GM, Olgin JE, Han F, Vedantham V, Tseng ZH, Pellegrini C, Kawamura M, Gerstenfeld EP, Badhwar N, Scheinman M. His overdrive pacing during supraventricular tachycardia: a novel maneuver for distinguishing atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia. Heart Rhythm. 2014 Aug; 11(8):1327-35.
  9. Hoffmayer KS, Dewland TA, Hsia HH, Badhwar N, Hsu JC, Tseng ZH, Marcus GM, Scheinman MM, Gerstenfeld EP. Safety of radiofrequency catheter ablation without coronary angiography in aortic cusp ventricular arrhythmias. Heart Rhythm. 2014 Jul; 11(7):1117-21.
  10. Riuró H, Campuzano O, Berne P, Arbelo E, Iglesias A, Pérez-Serra A, Coll-Vidal M, Partemi S, Mademont-Soler I, Picó F, Allegue C, Oliva A, Gerstenfeld E, Sarquella-Brugada G, Castro-Urda V, Fernández-Lozano I, Mont L, Brugada J, Scornik FS, Brugada R. Genetic analysis, in silico prediction, and family segregation in long QT syndrome. Eur J Hum Genet. 2015 Jan; 23(1):79-85.
  11. Stepanyan G, Badhwar N, Lee RJ, Marcus GM, Lee BK, Tseng ZH, Vedantham V, Olgin J, Scheinman M, Gerstenfeld EP. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol. 2014 Jun; 40(1):33-8.
  12. Kawamura M, Badhwar N, Vedantham V, Tseng ZH, Lee BK, Lee RJ, Marcus GM, Olgin JE, Gerstenfeld EP, Scheinman MM. Coupling interval dispersion and body mass index are independent predictors of idiopathic premature ventricular complex-induced cardiomyopathy. J Cardiovasc Electrophysiol. 2014 Jul; 25(7):756-62.
  13. Gerstenfeld EP. Contact force-sensing catheters: evolution or revolution in catheter ablation technology? Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):5-6.
  14. Nazer B, Gerstenfeld EP, Hata A, Crum LA, Matula TJ. Cardiovascular applications of therapeutic ultrasound. J Interv Card Electrophysiol. 2014 Apr; 39(3):287-94.
  15. Stepanyan G, Gerstenfeld EP. Atrial fibrillation ablation in octogenarians: where do we stand? Curr Cardiol Rep. 2013 Oct; 15(10):406.
  16. Mountantonakis SE, Gerstenfeld EP. Reply: The challenge of voltage channels. J Am Coll Cardiol. 2014 Jan 7-14; 63(1):90-1.
  17. Gerstenfeld EP, Everett TH. Internal atrial defibrillation revisited: how low can we go? J Am Coll Cardiol. 2014 Jan 7-14; 63(1):49-51.
  18. Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Oct; 2(5):e000428.
  19. Ermakov S, Hoffmayer KS, Gerstenfeld EP, Scheinman MM. Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy. Pacing Clin Electrophysiol. 2014 Jan; 37(1):90-4.
  20. Scheinman M, Gerstenfeld E. Mapping of complex atrial tachycardia circuits by 3-dimensional body surface mapping: the first step in the dawn of a new era. J Am Coll Cardiol. 2013 Sep 3; 62(10):898-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.